BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Short term Debt (2025 - 2026)

Updated

BioXcel Therapeutics' Short term Debt was $104.45 million in Q2 2026, up 831.3% from $11.22 million a year earlier and up 365.7% from the prior quarter.

Analysis

BioXcel Therapeutics (BTAIQ) Short term Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Short term Debt at BioXcel Therapeutics came in at $24.93 million.

  • Per Business Quant data, BTAIQ's Short term Debt in the three quarters before Q2 2026 was $22.43 million (Q1 2026), $24.93 million (Q4 2025) and $16.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104.45 Mn
Mar 31, 2026 22.43 Mn
Dec 31, 2025 24.93 Mn
Sep 30, 2025 16.82 Mn
Jun 30, 2025 11.22 Mn
Mar 31, 2025 5.61 Mn
API Access

BioXcel Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY